menu
Welcome to Orano Med
Orano Med is at the forefront of research in nuclear medicine and is developing new therapies against cancer. Based on its unique expertise in the production of lead-212 (Pb-212) and radiolabeling technologies, Orano Med is developing innovative radioligand therapies which consist of selectively destroying cancer cells while limiting the impact on surrounding healthy cells.
With a solid portfolio of molecules in development capable of targeting various forms of cancer, and a reliable supply chain for Pb-212, Orano Med aims to become a leader in targeted alpha therapies, in particular for patients with currently unmet medical needs.
Job description
Orano Med Theranostics
Orano Med is seeking a detail-oriented Pre-Clinical Scientist
We are seeking a highly motivated Pre-Clinical Scientist with expertise in radiopharmaceutical development to join our Research and Development team. The successful candidate will design, execute, and analyze preclinical studies to support the development of novel radiopharmaceutical compounds. This role offers an opportunity to contribute to groundbreaking therapies and collaborate with cross-functional teams to advance our pipeline toward clinical trials
Key Responsibilities
- Design and conduct in vivo and in vitro preclinical studies to evaluate the efficacy, safety, and pharmacokinetics of radiopharmaceutical compounds.
- Develop and optimize experimental protocols for radiopharmaceutical research, ensuring compliance with regulatory standards (e.g., GLP).
- Analyze and interpret complex datasets, preparing detailed reports and presentations for internal stakeholders and regulatory submissions.
- Collaborate with chemistry, and clinical teams to support IND-enabling studies and translate preclinical findings to clinical applications.
- Maintain accurate records of experiments and ensure data integrity in accordance with company policies.
- Stay current with advancements in radiopharmaceutical science and contribute to the development of innovative research strategies.
Orano strives to provide a total compensation package that brings value to our employees. We also offer highly competitive health and wellness programs, 401(k) contributions, and industry leading paid time off.
Our Full-Time Benefits
- Competitive compensation
- Health, Dental, and Vision insurance – with generous employer contributions
- 401(k) with employer matching and contribution amounts
- Life insurance and Short- and Long-Term Disability insurance provided by the company
- Generous Paid Time Off and holiday schedules
- Numerous Training and Development opportunities
- and more…
Ideal qualifications
Education & Experience
All candidates must meet the following minimum requirements in order to be considered for this opportunity. Candidates who exceed minimum qualifications may be considered for a higher-level position.
Minimum Qualifications:
- Ph.D. in pharmacology, biology, chemistry, or a related field.
- 3+ years of experience in preclinical research, with a strong preference for expertise in radiopharmaceutical development.
- Hands-on experience in animal experimentation
- Familiarity with regulatory requirements for preclinical studies and IND submissions
Required Skills & Competencies:
- Proficiency in data analysis tools (e.g., GraphPad Prism, or similar).
- Strong understanding of rodent biology and biodistribution in radiopharmaceutical research.
- Excellent written and verbal communication skills for scientific reporting and collaboration.
- Ability to work independently and manage multiple projects
Preferred Skills & Competencies:
- Experience with handling radioactive materials.
Orano Med LLC - Plano TX
Orano Med is at the forefront of research in nuclear medicine and is developing new therapies against cancer. Based on its unique expertise in the production of lead-212 (Pb-212) and radiolabeling technologies, Orano Med is developing innovative radioligand therapies which consist of selectively destroying cancer cells while limiting the impact on surrounding healthy cells. With a solid portfolio of molecules in development capable of targeting various forms of cancer, and a reliable supply chain for Pb-212, Orano Med aims to become a leader in targeted alpha therapies, in particular for patients with currently unmet medical needs.
Find out more about Orano Med
Find out more about Orano Med